Cancer Program Should Get $2 Billion A Year, Amos Says; “Feds Short On Money, Long of Regs”: Yarbro
In Brief: ACS Considers Expanding Psychosocial Program, Taylor Says; Mendelsohn, Pitot Join NTP Board
Cooperative Groups With Cancer Control Contracts Receive Two Year Renewals
NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity
Pancreatic Lesions Related To Corn Oil Status Reports Made
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally
- UT Austin announces first tech-native academic medical center in the U.S.
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Problem: Misinformation and stigma prevent uptake of HPV vaccines and screening. Solution: A comic book









